Explore the details of the Pfizer Inc. V. Dexcel Pharma Technologies Limited case under case number 1:23-cv-00879 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:23-cv-00879
Filing Date
Aug 10, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
FoldRx Pharmaceuticals, LLC -
Cipla Limited -
PF PRISM IMB B.V. -
Aurobindo Pharma Limited -
The Scripps Research Institute -
Zenara Pharma Private Limited -
Dexcel Pharma Technologies Limited -
Wyeth LLC -
Pfizer Inc. -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jun 23, 2025NOTICE OF SERVICE of Plaintiffs' Fifth Supplemental Responses and Objections to Defendants' First Set of Collective Interrogatories (Nos. 1-3) - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan)PACER Document
Jun 27, 2025[SEALED] STIPULATION and [Proposed] Order Regarding Limited Extension of Fact Discovery Deadline for Completion of Foreign Discovery by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan)PACER Document
Jun 27, 2025STIPULATION and [PROPOSED] Order regarding Authenticity and Admissibility of Documents by Cipla Limited. (Taylor, Daniel)PACER Document
Jun 27, 2025SO ORDERED, D.I. 211 Stipulation and [PROPOSED] Order regarding Authenticity and Admissibility of Documents by Cipla Limited. Ordered by Judge Christopher J. Burke on 06/27/2025. (sam)PACER Document
Jun 27, 2025NOTICE OF SERVICE of Defendants' confidential Opening Expert Report of Dr. Michael Zaworotko, Ph.D. filed by Cipla Limited.(Taylor, Daniel)PACER Document
Jun 27, 2025NOTICE OF SERVICE of 1) Opening Expert Report of Jerry L. Atwood, Ph.D.; 2) Opening Expert Report of David E. Bugay, Ph.D.; 3) Opening Expert Report of Karthikeyan Ananthasubramaniam, M.D.; and 4) Expert Report of Sylvia D. Hall-Ellis, Ph.D. filed by Dexcel Pharma Technologies Limited.(Mackrides, Daniel)PACER Document
Jun 27, 2025NOTICE OF SERVICE of Opening Expert Report of Dr. Michael Zaworotko, Ph. D. filed by Dexcel Pharma Technologies Limited.(Mackrides, Daniel)PACER Document
Jun 30, 2025SO ORDERED, re 210 Stipulation Regarding Limited Exension of Fact Discovery Deadline for Completion of Foreign Discovery, filed by Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Pfizer Inc., The Scripps Research Institute. Signed by Judge Gregory B. Williams on 6/30/2025. (lnb)PACER Document
Jun 30, 2025NOTICE OF SERVICE of (1) Opening Expert Report of Adam Matzger, Ph.D. and (2) Report of Aeri Park, Ph.D. Regarding Cipla's Samples filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan)PACER Document
Jun 30, 2025NOTICE OF SERVICE of (1) Opening Expert Report of Adam Matzger, Ph.D. and (2) Report of Aeri Park, Ph.D. Regarding Zenara's (Hikma's) Samples filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan)PACER Document
Jul 3, 2025REDACTED VERSION of [210] Stipulation, by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan)PACER Document
Jul 11, 2025NOTICE of Withdrawal of Counsel by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC (Dellinger, Megan)PACER Document
Jul 22, 2025NOTICE to Take Deposition of Shane Shupe on July 24, 2025 filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Tigan, Jeremy)PACER Document
Jul 31, 2025[SEALED] STIPULATION and [Proposed] Order Regarding Limited Extension of Fact Discovery Deadline for Completion of Foreign Discovery by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan)PACER Document
Jul 31, 2025SO ORDERED, D.I. 220 Stipulation and Order Regarding Limited Extension of Fact Discovery Deadline for Completion of Foreign Discovery filed by Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Pfizer Inc., The Scripps Research Institute. Ordered by Judge Christopher J. Burke on 07/31/2025. (sam)PACER Document
Aug 6, 2025REDACTED VERSION of [220] Stipulation, by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan)PACER Document